| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025179220 |
| P356 | DOI | 10.1007/S00441-013-1681-Z |
| P932 | PMC publication ID | 3964207 |
| P698 | PubMed publication ID | 23881404 |
| P50 | author | Onesmo B Balemba | Q87440457 |
| P2093 | author name string | Martin Gericke | |
| Adam J Kappmeyer | |||
| Chloe M Stenkamp-Strahm | |||
| Joe T Schmalz | |||
| P2860 | cites work | High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse | Q21136177 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 | ||
| The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes | Q31131756 | ||
| Myenteric plexus of obese diabetic mice (an animal model of human type 2 diabetes). | Q31978307 | ||
| Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults | Q33423654 | ||
| The enteric nervous system and regulation of intestinal motility. | Q33547217 | ||
| Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment | Q33676530 | ||
| Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress | Q33715744 | ||
| Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation | Q34085293 | ||
| Post-translational processing of synaptophysin in the rat retina is disrupted by diabetes | Q34412739 | ||
| Diabetes and obesity: the twin epidemics | Q34482313 | ||
| Gastric bypass reduces fat intake and preference. | Q35395094 | ||
| Evaluation and prevention of diabetic neuropathy. | Q36161070 | ||
| Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy | Q36196652 | ||
| Diabetic state affects the innervation of gut in an animal model of human type 1 diabetes | Q74236702 | ||
| Changes of the different neuropeptide-containing nerve fibers and immunocells in the diabetic rat's alimentary tract | Q79411472 | ||
| Hypothyroid states mitigate the diabetes-induced reduction of calbindin D-28k, calretinin, and parvalbumin immunoreactivity in type 2 diabetic rats | Q82258700 | ||
| Glial-derived neurotrophic factor modulates enteric neuronal survival and proliferation through neuropeptide Y. | Q36596568 | ||
| Diabetes mellitus and the peripheral nervous system: manifestations and mechanisms | Q36806531 | ||
| Diabetes and the enteric nervous system | Q36986128 | ||
| Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. | Q37360464 | ||
| Prediabetic neuropathy: does it exist? | Q38007899 | ||
| Diet-induced obesity has neuroprotective effects in murine gastric enteric nervous system: involvement of leptin and glial cell line-derived neurotrophic factor | Q39436138 | ||
| Loss of enteric neurons accompanied by decreased expression of GDNF and PI3K/Akt pathway in diabetic rats | Q39807936 | ||
| Gastroparesis and dyspepsia in patients with diabetes mellitus. | Q40381585 | ||
| Plurichemical transmission and chemical coding of neurons in the digestive tract. | Q40579546 | ||
| Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. | Q40607112 | ||
| Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes | Q40693328 | ||
| Pathophysiology of diabetic gastroparesis | Q40883202 | ||
| Quantitative ultrastructural analysis of enkephalin-, substance P-, and VIP-immunoreactive nerve fibers in the circular muscle of the guinea pig small intestine | Q42489076 | ||
| Antidiabetic effects of duodenojejunal bypass in an experimental model of diabetes induced by a high-fat diet | Q43713138 | ||
| Enhanced colonic peristalsis by impairment of nitrergic enteric neurons in spontaneously diabetic rats | Q43746682 | ||
| Morphoquantitative effects of acute diabetes on the myenteric neurons of the proximal colon of adult rats | Q44147335 | ||
| Distribution and chemical coding of cocaine- and amphetamine-regulated transcript peptide (CART)-immunoreactive neurons in the guinea pig bowel | Q44455135 | ||
| Effects of gender, age, and body mass index on gastrointestinal transit times | Q44456437 | ||
| Quantification of neurons in the myenteric plexus: an evaluation of putative pan-neuronal markers | Q44752210 | ||
| Prevention and partial reversal of diabetes-induced changes in enteric nerves of the rat ileum by combined treatment with alpha-lipoic acid and evening primrose oil. | Q44862445 | ||
| Selective responses of myenteric neurons to oxidative stress and diabetic stimuli | Q44897980 | ||
| Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats | Q44985168 | ||
| Diet-induced type II diabetes in C57BL/6J mice | Q45730735 | ||
| Immunohistochemical analysis of neuron types in the mouse small intestine | Q46316774 | ||
| Choline acetyltransferase and inducible nitric oxide synthase are increased in myenteric plexus of diabetic guinea pig. | Q46408136 | ||
| Depletion of peptidergic innervation in the gastric mucosa of streptozotocin-induced diabetic rats. | Q46451343 | ||
| Intestinal peristalsis associated with release of immunoreactive substance P | Q46598921 | ||
| Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study | Q46618643 | ||
| Number and size of myenteric neurons of the duodenum of adult rats with acute diabetes | Q47221360 | ||
| Size of neurons and glial cells in the enteric ganglia of mice, guinea-pigs, rabbits and sheep | Q47242623 | ||
| Morphological and quantitative analysis of the neurons of the myenteric plexus of the cecum of streptozotocin-induced diabetic rats | Q47966319 | ||
| Neuropeptide contents in the duodenum of non-obese diabetic mice | Q47979636 | ||
| The identification and chemical coding of cholinergic neurons in the small and large intestine of the mouse | Q47981487 | ||
| Regional differences in the number of neurons in the myenteric plexus of the guinea pig small intestine and colon: an evaluation of markers used to count neurons. | Q50750700 | ||
| Evidence that nitric oxide participates in non-adrenergic inhibitory transmission to intestinal muscle in the guinea-pig. | Q51706160 | ||
| Altered expression of neuronal nitric oxide synthase in the duodenum longitudinal muscle-myenteric plexus of obesity induced diabetes mouse: implications on enteric neurodegeneration. | Q51834701 | ||
| Differential effect of streptozotocin-induced diabetes on the innervation of the ileum and distal colon. | Q52237301 | ||
| Targeted disruption of the neuronal nitric oxide synthase gene. | Q52507290 | ||
| Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs. | Q53899605 | ||
| L-glutamine supplementation prevents myenteric neuron loss and has gliatrophic effects in the ileum of diabetic rats | Q57119115 | ||
| Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release | Q62479359 | ||
| Chemical coding of neurons in the myenteric plexus and external muscle of the small and large intestine of the mouse | Q62583097 | ||
| Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers | Q68339995 | ||
| Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat | Q68942934 | ||
| Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion | Q69169662 | ||
| Effects of chronic experimental streptozotocin-induced diabetes on the noradrenergic and peptidergic innervation of the rat alimentary tract | Q69928725 | ||
| The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study | Q70651014 | ||
| [Ultrastructure of diabetic autonomic neuropathy of the gastrointestinal tract] | Q71364490 | ||
| Upper limit for intestinal absorption of a dilute glucose solution in men at rest | Q73234426 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 381-394 | |
| P577 | publication date | 2013-07-24 | |
| P1433 | published in | Cell and Tissue Research | Q1524113 |
| P1476 | title | High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes | |
| P478 | volume | 354 |
| Q43083601 | Adult enteric nervous system in health is maintained by a dynamic balance between neuronal apoptosis and neurogenesis. |
| Q48325676 | Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice |
| Q48332702 | Antidiarrheal effect of sodium hydrosulfide in diabetic rats: In vitro and in vivo studies |
| Q50468098 | Damage to enteric neurons occurs in mice that develop fatty liver disease but not diabetes in response to a high-fat diet. |
| Q40486031 | Delayed gastric emptying in diabetic rats caused by decreased expression of cystathionine gamma lyase and H2 S synthesis: in vitro and in vivo studies. |
| Q33682828 | Enteric innervation combined with proteomics for the evaluation of the effects of chronic fluoride exposure on the duodenum of rats |
| Q34562889 | Exercise increases cutaneous nerve density in diabetic patients without neuropathy |
| Q94593969 | GASTROINTESTINAL MOTILITY DISORDERS IN OBESITY |
| Q90347934 | Gastroparesis: a turning point in understanding and treatment |
| Q38303452 | High-fat diet promotes neuronal loss in the myenteric plexus of the large intestine in mice. |
| Q90304410 | High-fat diet-induced alterations to gut microbiota and gut-derived lipoteichoic acid contributes to the development of enteric neuropathy |
| Q40989854 | High-fat diet-induced obesity alters nitric oxide-mediated neuromuscular transmission and smooth muscle excitability in the mouse distal colon. |
| Q55514856 | Impact of Intestinal Peptides on the Enteric Nervous System: Novel Approaches to Control Glucose Metabolism and Food Intake. |
| Q35047606 | Intestinal and neuronal myenteric adaptations in the small intestine induced by a high-fat diet in mice |
| Q37095241 | Intestinal dysbiosis contributes to the delayed gastrointestinal transit in high-fat diet fed mice |
| Q43156402 | Myosin Va but Not nNOSα is Significantly Reduced in Jejunal Musculomotor Nerve Terminals in Diabetes Mellitus |
| Q59329759 | Neuroprotective effects of vitamin D on high fat diet- and palmitic acid-induced enteric neuronal loss in mice |
| Q35728214 | Non-alcoholic fatty liver disease, diet and gut microbiota. |
| Q36328386 | Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis |
| Q38845165 | Postnatal Development of the Mouse Enteric Nervous System |
| Q41905246 | Prolonged high fat diet ingestion, obesity, and type 2 diabetes symptoms correlate with phenotypic plasticity in myenteric neurons and nerve damage in the mouse duodenum |
| Q97681256 | Sodium-glucose co-transporter (SGLT) inhibitor restores lost axonal varicosities of the myenteric plexus in a mouse model of high-fat diet-induced obesity |
| Q34944800 | Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients. |
| Q40401028 | Western diet induces colonic nitrergic myenteric neuropathy and dysmotility in mice via saturated fatty acid- and lipopolysaccharide-induced TLR4 signalling. |
| Q26750556 | White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies |
Search more.